WTAP regulates DDX3Y mRNA via m6A modification to promote high glucose-induced podocytes injury and diabetic

Guanxi Li1, Huijuan Zeng1, Guojia Ru1

  • 1The Second Department of Nephrology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.

PubMed

Insights

Wilms' tumor 1-associating protein (WTAP) promotes diabetic nephropathy (DN) by stabilizing DDX3Y mRNA through N6-methyladenosine (m6A) modification, leading to podocyte injury and kidney damage.

Area of Science:

  • Epigenetics
  • Molecular Biology
  • Nephrology

Background:

  • Diabetic nephropathy (DN) is a severe diabetes complication with significant health and economic impacts.
  • N6-methyladenosine (m6A) modification is a key epigenetic regulator affecting cellular functions and disease development.
  • Wilms' tumor 1-associating protein (WTAP) is a crucial component of the m6A methyltransferase complex.

Purpose of the Study:

  • To investigate the role of WTAP in diabetic nephropathy (DN).
  • To elucidate the molecular mechanism by which WTAP influences DN progression.
  • To explore the potential of targeting the WTAP/DDX3Y axis in DN treatment.

Main Methods:

  • Bioinformatic analysis of differentially expressed genes in DN.
  • Establishment of a high glucose (HG)-induced podocyte model in vitro.
  • Western blot, CCK-8, ELISA, flow cytometry, and TUNEL assays for cellular analysis.
  • MeRIP and xenograft models for validating m6A modification and in vivo effects.

Main Results:

  • WTAP and DDX3Y expression were elevated in DN conditions and HG-induced podocytes.
  • Knockdown of DDX3Y (sh-DDX3Y) alleviated HG-induced podocyte injury.
  • WTAP enhanced DDX3Y mRNA stability through m6A methylation, worsening podocyte dysfunction.
  • WTAP/DDX3Y modulation in diabetic mice led to renal insufficiency and histopathological damage.

Conclusions:

  • WTAP promotes podocyte injury and DN progression via m6A-mediated regulation of DDX3Y stability.
  • The WTAP/DDX3Y pathway represents a potential therapeutic target for diabetic nephropathy.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.3K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.4K